Telangiectasis Clinical Trial
Official title:
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias
After diagnose Yuxtafoveal telangiectasias secondary to Branch Retinal Vein Occlusion and with Idiopathic Ethiology by clinical signs and Fluorescein angiogram (FA)findings we treated patients with Intravitreal Injection of Bevacizumab (2.5mg/0.1ml). We performed a complete ophthalmological evaluation and at baseline and follow-up (1 and 3 months) we evaluate ETDRS Best Corrected visual acuity (BCVA), fluorescein angiogram (FA) and Optical Coherence Tomography (OCT)findings. We found an improvement in visual acuity and reduction of FA leakage and decrease retinal thickness in OCT. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00005392 -
Epidemiology of Venous Disease
|
N/A | |
Completed |
NCT00005386 -
Biobehavioral Determinants of Obesity in Black Women
|
N/A | |
Completed |
NCT01205035 -
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
|
Phase 2 | |
Completed |
NCT01362192 -
Treatment of Lower Extremity Spider Veins With Excel V
|
Phase 4 | |
Completed |
NCT00725244 -
Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias
|
Phase 4 | |
Withdrawn |
NCT02090517 -
Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
|
N/A | |
Completed |
NCT02657252 -
Polidocanol Versus Glucose Treatment of Telangiectasia Trial
|
Phase 4 | |
Completed |
NCT02104271 -
Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.
|
Phase 2 | |
Completed |
NCT00451763 -
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
|
Phase 3 | |
Completed |
NCT05860439 -
Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias
|
||
Recruiting |
NCT00206921 -
Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness
|
N/A |